Acute tubulointerstitial nephritis attributable to indinavir therapy

被引:28
作者
Jaradat, M
Phillips, C
Yum, MN
Cushing, H
Moe, S
机构
[1] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46202 USA
关键词
indinavir; crystalluria; calculi; human immunodeficiency virus (HIV); acute renal failure;
D O I
10.1016/S0272-6386(00)70034-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Indinavir sulfate has been reported to cause asymptomatic crystalluria and nephrolithiasis in patients with human immunodeficiency virus (HIV) infection. Patients taking indinavir may present with asymptomatic crystalluria, nephrolithiasis with frank renal colic and obstruction, flank pain in the absence of nephrolithiasis, and dysuria or urgency, Asymptomatic crystalluria has been described as benign. Discontinuation of the drug has not been recommended in the absence of nephrolithiasis. We report two HIV-positive patients receiving indinavir who developed acute interstitial nephritis with foreign body giant cell reaction on renal biopsies. Both patients had asymptomatic crystalluria, although crystals were associated with clumps of white blood cells (WBCs) on urinalysis in one patient. Both cases show that the inflammatory response was significant enough to lead to tubular injury and acute renal impairment. Our findings suggest that asymptomatic crystalluria attributable to indinavir may illicit an inflammatory response with acute renal insufficiency, warranting monitoring of renal function, especially in patients with crystalluria, (C) 2000 by the National Kidney Foundation, Inc.
引用
收藏
页码:art. no. / E16
页数:5
相关论文
共 21 条
[1]  
[Anonymous], CRIX IND SULF PACK I
[2]   Sulfadiazine-associated nephrotoxicity in patients with the acquired immunodeficiency syndrome [J].
Becker, K ;
Jablonowski, H ;
Haussinger, D .
MEDICINE, 1996, 75 (04) :185-194
[3]   Acute renal failure due to indinavir crystalluria and nephrolithiasis: Report of two cases [J].
Berns, JS ;
Cohen, RM ;
Silverman, M ;
Turner, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (04) :558-560
[4]   Antiretroviral therapy for HIV infection in 1998 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :78-86
[5]  
Chen SCA, 1998, AIDS, V12, P440
[6]  
DAgati V, 1997, J AM SOC NEPHROL, V8, P138
[7]   Renal dysfunction in a human immunodeficiency virus-infected patient who was treated with indinavir [J].
Grunke, M ;
Valerius, T ;
Manger, B ;
Kalden, JR ;
Harrer, T .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (05) :1270-1271
[8]   Renal atrophy associated with long-term treatment with indinavir [J].
Hanabusa, H ;
Tagami, H ;
Hataya, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (05) :392-393
[9]   Indinavir urolithiasis: An emerging cause of renal colic in patients with human immunodeficiency virus [J].
Kohan, AD ;
Armenakas, NA ;
Fracchia, JA .
JOURNAL OF UROLOGY, 1999, 161 (06) :1765-1768
[10]   Crystalluria and urinary tract abnormalities associated with indinavir [J].
Kopp, JB ;
Miller, KD ;
Mican, JAM ;
Feuerstein, IM ;
Vaughan, E ;
Baker, C ;
Pannell, LK ;
Falloon, J .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (02) :119-+